Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q2 2016 · 10-Q
Revenue$5.33B$5.33B+3.2% vs Q2 2015 Net Income$615.00M$615.00M−21.6% vs Q2 2015 EPS Diluted$0.41$0.41−21.2% vs Q2 2015 Gross Profit$2,901,000,000+3.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$909,000,000−3.4% Free Cash Flowderived$662,000,000−8.7% Margins · derivedGross margin54.4%+0.2 pt vs Q2 2015
Operating margin15.3%+1.2 pt vs Q2 2015
Net margin11.5%−3.6 pt vs Q2 2015
ended Jun 30, 2016 · filed Aug 3, 2016 · 34 d after period end